1. Home
  2. STC vs NVCR Comparison

STC vs NVCR Comparison

Compare STC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$70.17

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.94

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STC
NVCR
Founded
1893
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
STC
NVCR
Price
$70.17
$12.94
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$81.50
$28.42
AVG Volume (30 Days)
261.3K
1.5M
Earning Date
02-04-2026
10-30-2025
Dividend Yield
2.99%
N/A
EPS Growth
69.60
N/A
EPS
3.60
N/A
Revenue
$2,796,513,000.00
$642,269,000.00
Revenue This Year
$17.67
$9.75
Revenue Next Year
$10.14
$5.62
P/E Ratio
$19.52
N/A
Revenue Growth
16.09
11.17
52 Week Low
$56.39
$10.70
52 Week High
$78.61
$31.17

Technical Indicators

Market Signals
Indicator
STC
NVCR
Relative Strength Index (RSI) 40.08 52.14
Support Level $70.90 $12.30
Resistance Level $72.68 $13.64
Average True Range (ATR) 1.92 0.48
MACD -0.38 0.02
Stochastic Oscillator 9.68 39.89

Price Performance

Historical Comparison
STC
NVCR

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: